Cytori Therapeutics, Inc. to Raise $13.5 Million in Registered Direct Offering
MarketWatch At closing, Cytori will issue and sell to select investors 13,500 units, with each unit consisting of one share of its Series A 3.6% convertible preferred stock, which shall be convertible into the Company’s common stock (the “Conversion Shares”) and … |